Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.

Item
http://www.wikidata.org/entity/Q37575208
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis.Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent.Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.Current and future therapeutic approaches for osteosarcoma.Biology of Bone Sarcomas and New Therapeutic Developments.Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1.Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers.Mechanisms of Intrinsic Tumor Resistance to Immunotherapy.Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling PathwayReport from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma
P2860

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.

Item
http://www.wikidata.org/entity/Q37575208
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@en
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@nl
type
label
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@en
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@nl
prefLabel
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@en
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Increased PD-L1 and T-cell inf ...... or T-cell-based immunotherapy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932